Articles published by Mirum Pharmaceuticals, Inc.

< Previous 1 2 3 4 5 6 7 8 Next >

Mirum Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call on May 6, 2021

April 29, 2021

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Tickers MIRM

Mirum Pharmaceuticals and CANbridge Pharmaceuticals Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat in Greater China for Rare Liver Diseases

April 29, 2021

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Tickers MIRM

Mirum Pharmaceuticals Receives Notice of Allowance for Methods of Use Patent for Maralixibat in Alagille Syndrome

April 26, 2021

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Tickers MIRM

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 12, 2021

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Tickers MIRM

Mirum Pharmaceuticals and Vivet Therapeutics Enter into Exclusive Worldwide Option and License Agreement for Vivet’s Gene Therapy Programs Targeting Progressive Familial Intrahepatic Cholestasis

April 12, 2021

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Tickers MIRM

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.